Citation: Ey. Kim et al., Anti-HIV type 1 activity of 3 '-fluoro-3 '-deoxythymidine for several different multidrug-resistant mutants, AIDS RES H, 17(5), 2001, pp. 401-407
Authors:
Pyring, D
Lindberg, J
Rosenquist, A
Zuccarello, G
Kvarnstrom, I
Zhang, H
Vrang, L
Unge, T
Classon, B
Hallberg, A
Samuelsson, B
Citation: D. Pyring et al., Design and synthesis of potent C-2-symmetric diol-based HIV-1 protease inhibitors: Effects of fluoro substitution, J MED CHEM, 44(19), 2001, pp. 3083-3091
Authors:
Hamalainen, MD
Markgren, PO
Schaal, W
Karlen, A
Classon, B
Vrang, L
Samuelsson, B
Hallberg, A
Danielson, UH
Citation: Md. Hamalainen et al., Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen, J BIOMOL SC, 5(5), 2000, pp. 353-359
Authors:
Hogberg, M
Engelhardt, P
Vrang, L
Zhang, H
Citation: M. Hogberg et al., Bioisosteric modification of PETT-HIV-1 RT-inhibitors: Synthesis and biological evaluation, BIOORG MED, 10(3), 2000, pp. 265-268
Authors:
Hogberg, M
Sahlberg, C
Engelhardt, P
Noreen, R
Kangasmetsa, J
Johansson, NG
Oberg, B
Vrang, L
Zhang, H
Sahlberg, BL
Unge, T
Lovgren, S
Fridborg, K
Backbro, K
Citation: M. Hogberg et al., Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. (vol 42, pg 4145, 1999), J MED CHEM, 43(2), 2000, pp. 304-304
Authors:
Hogberg, M
Sahlberg, C
Engelhardt, P
Noreen, R
Kangasmetsa, J
Johansson, NG
Oberg, B
Vrang, L
Zhang, H
Sahlberg, BL
Unge, T
Lovgren, S
Fridborg, K
Backbro, K
Citation: M. Hogberg et al., Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues, J MED CHEM, 42(20), 1999, pp. 4150-4160
Authors:
Alterman, M
Andersson, HO
Garg, N
Ahlsen, G
Lovgren, S
Classon, B
Danielson, UH
Kvarnstrom, I
Vrang, L
Unge, T
Samuelsson, B
Hallberg, A
Citation: M. Alterman et al., Design and fast synthesis of C-terminal duplicated potent C-2-symmetric P1/P1 '-modified HIV-1 protease inhibitors, J MED CHEM, 42(19), 1999, pp. 3835-3844